Filed: 2/18/2026ACC: 0001193125-26-055455
📋 What this filing means
YU FAN filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $92.27M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$92.27M
Total AUM (reported)
7.19M
Total Shares
Allocation by class
SHS$60.53M65.6%
COM$24.77M26.8%
ADS$6.97M7.6%
Portfolio Concentration
Top 3$80.29M87.0%
4–10$11.98M13.0%
Top 3 weight
87.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.19M
Sole
Full voting authority
7.19M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
KESTRA MED TECHNOLOGIES LTD
SOLEShares2.28M
TypeSH
Market value$60.53M
65.60%
Sole
2.28M
Shared
0.00
None
0.00
CERIBELL INC
SOLEShares549.45K
TypeSH
Market value$12.05M
13.06%
Sole
549.45K
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares789.62K
TypeSH
Market value$7.71M
8.35%
Sole
789.62K
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares1.50M
TypeSH
Market value$6.97M
7.56%
Sole
1.50M
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares2.07M
TypeSH
Market value$5.01M
5.43%
Sole
2.07M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KESTRA MED TECHNOLOGIES LTDSOLE | SHS | 2.28M | SH | $60.53M 65.60% | 2.28M | 0.00 | 0.00 |
CERIBELL INCSOLE | COM | 549.45K | SH | $12.05M 13.06% | 549.45K | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 789.62K | SH | $7.71M 8.35% | 789.62K | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 1.50M | SH | $6.97M 7.56% | 1.50M | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 2.07M | SH | $5.01M 5.43% | 2.07M | 0.00 | 0.00 |